Related Experiment Video

Updated: Aug 7, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Combined therapy with percutaneous coronary intervention and percutaneous aortic valvuloplasty under mechanical

Koji Kato1, Naoki Sato, Nobuhiko Fujita

  • 1Intensive and Cardiac Care Unit, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan. katokoji@nms.ac.jp

Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
|June 23, 2006
PubMed

Insights

This study shows that combining percutaneous coronary intervention and aortic valvuloplasty effectively treated a patient with severe aortic stenosis and cardiogenic shock. This combined approach reversed shock and allowed for device weaning.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Severe aortic stenosis can lead to cardiogenic shock, a life-threatening condition.
  • Percutaneous aortic valvuloplasty (PAV) is a treatment option for severe aortic stenosis.
  • Percutaneous coronary intervention (PCI) is crucial for acute myocardial infarction with cardiogenic shock, especially in elderly patients.

Observation:

  • A patient with critical aortic stenosis presented with severe coronary stenosis involving the left main trunk and right coronary artery ostium.
  • The patient experienced cardiogenic shock secondary to the combined cardiac conditions.

Findings:

  • A combined strategy of PCI and PAV was successfully performed.
  • The procedures were supported by an intra-aortic balloon pump (IABP) and percutaneous cardiopulmonary support (PCPS).
  • Following the interventions, the patient's cardiogenic shock resolved, and they were successfully weaned from IABP and PCPS.

Implications:

  • This case demonstrates the feasibility and effectiveness of a combined PCI and PAV approach in managing complex cases of severe aortic stenosis with cardiogenic shock.
  • Such combined interventions may offer a viable therapeutic option for critically ill patients with concurrent coronary and aortic valve disease.
  • The successful management highlights the importance of addressing both coronary and valvular pathologies simultaneously in cardiogenic shock patients.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...